Biotechnology News and Research

RSS

Max Neeman International forms specialized surgical team for conducting minimally invasive surgery studies

Max Neeman International, a leading Indian CRO, has formed an exclusive team of India's finest, most experienced Physicians to conduct Minimally Invasive Surgery Studies. The team consists of the best Minimal Access Surgeons in the country who have performed more than 25,000 procedures combined.

16 Feb 2010

Teva Pharmaceutical Industries announces fourth-quarter and full-year 2009 financial results

Teva Pharmaceutical Industries Ltd. today reported record results for the quarter and year ended December 31, 2009.

16 Feb 2010

Over 96% of SIDS cases due to known risk factors

Sudden Infant Death Syndrome (SIDS) continues to be the third leading cause of infant death, according to the Centers for Disease Control (CDC), despite a decline in SIDS that is associated with a rise in safe-sleep practices for newborns and infants. A new study by Barbara M. Ostfeld, PhD and Thomas Hegyi, MD, professors in the Department of Pediatrics at UMDNJ-Robert Wood Johnson Medical School, has identified that more than 96 percent of infants who died of SIDS were exposed to known risk factors, among them sleeping on their side or stomach, or exposure to tobacco smoke, and that 78 percent of SIDS cases contained multiple risk factors.

16 Feb 2010

US Oncology honored as inaugural inductee to Texas Governor's Business Hall of Fame

US Oncology, Inc., the nation's premier oncology services company supporting the nation's largest network including more than 1,300 oncologists and more than 10,000 clinicians and cancer experts to advance cancer care in America, was honored on Feb. 6, by Texas Governor Rick Perry at the Texas vs. the Nation All-Star Football Challenge in El Paso, Texas. US Oncology was honored as an inaugural inductee to the Governor's Business Hall of Fame along with Baker Hughes, Bell Helicopter, and Texas Instruments.

16 Feb 2010

Teva Pharmaceuticals USA settles famciclovir patent litigation with Novartis

Teva Pharmaceutical Industries Ltd. today announced that its subsidiary, Teva Pharmaceuticals USA, Inc., has signed an agreement with Novartis to settle patent litigation involving Teva’s U.S. generic version of Novartis’ Famvir® (famciclovir) 125 mg, 250 mg and 500 mg tablets including all claims for patent infringement and damages. Teva launched its generic famciclovir tablets in the U.S. in September 2007.

16 Feb 2010

U.S. Department of Labor awards $4.95M grant for BRIDGE biotechnology project

San Diego State University, BIOCOM, San Diego Workforce Partnership, and the Southern California Biotechnology Center at Miramar College today announced the award of a three-year, $4.95 million grant from the U.S. Department of Labor aimed at assisting the economic growth of the San Diego region's life sciences industry. The Biotechnology Readiness, Immersion, Certification and Degrees for Gainful Employment (BRIDGE) project will provide education, training, and placement services to more than 1,000 veterans, incumbent workers and dislocated and unemployed workers within the San Diego region.

16 Feb 2010

International discussion held to find solutions for agricultural challenges of all time

An eminent panel of science and policy experts braved a historic blizzard today to identify solutions for the greatest agricultural challenges of all time. The global dialogue comes in response to a final call for action from the late Nobel Laureate, Dr. Norman Borlaug, to feed the world and improve the lives of farmers, all while preserving natural resources.

15 Feb 2010

Research findings may open door to new therapeutic strategies for serious health problems

Drugs that target the way cells convert nutrients into energy could offer new approaches to treating a range of conditions including heart attack and stroke. Using a new way to screen for potential drugs, a team led by Massachusetts General Hospital (MGH) researchers has identified several FDA-approved agents, including an over-the-counter anti-nausea drug, that can shift cellular energy metabolism processes in animals.

15 Feb 2010

High-resolution still images alongside high-speed video footage for detailed scientific imaging

Scientists funded by the Biotechnology and Biological Sciences Research Council and the British Heart Foundation at the University of Oxford have developed a revolutionary way of capturing a high-resolution still image alongside very high-speed video - a new technology that is attractive for science, industry and consumer sectors alike.

15 Feb 2010

Isogenica enters into agreement with Dstl to develop antimicrobial peptide drugs

Isogenica Ltd today announced that it has entered into an agreement with UK Ministry of Defence agency, the Defence Science and Technology Laboratory. The agreement concerns the development of antimicrobial peptide drugs and follows a successful collaboration to identify highly effective antimicrobial peptides which are active against a broad spectrum of bacteria.

15 Feb 2010

TAP to showcase ambr system at Cell Line Development and Engineering 2010

The Automation Partnership, a world leader in the design and development of innovative automation for life science applications, is pleased to announce it will be showcasing its new advanced micro bioreactor system (ambr™) at Cell Line Development and Engineering 2010, February 25-26 in San Francisco, USA.

15 Feb 2010

Genencor launches Accellerase DUET at the 15th Annual National Ethanol Conference in Orlando

Genencor, a division of Danisco A/S, today introduced Accellerase® DUET at the Renewable Fuels Association's 15th Annual National Ethanol Conference in Orlando, Fla. This product is the latest generation in the company's line of enzymes used to convert biomass into sugars, a critical step in the production of cellulosic ethanol and other advanced biofuels and biochemicals from non-food feedstocks.

15 Feb 2010

Free educational webinar: Important aspects to be aware of when selecting EHR system

Community oncologists, practice administrators (PAs), executive directors (EDs), and clinical staff interested in learning the most important aspects to be aware of when selecting the Electronic Health Record (EHR) system most appropriate for your particular practice are invited to attend a free webinar at 2 p.m. EST (11 a.m. PST) on Thursday, Feb. 18, 2010.

15 Feb 2010

Hypnosis has potential therapeutic value in children with respiratory disorders

Hypnosis has potential therapeutic value in children with respiratory disorders for alleviating symptoms such as habit cough or unexplained sensations of difficulty breathing and for lessening a child's discomfort during medical procedures.

15 Feb 2010

GM crops can help bolster global food security, scientists say in special journal issue

Acceptance of genetically modified (GM) crops in agriculture will help bolster global food security as the world faces population growth and the potential effects of climate change, Nina Fedoroff, science and technology advisor to Secretary of State Hillary Rodham Clinton, and colleagues write in an article published in a special issue of the journal Science, the Times of London reports.

15 Feb 2010

VR technology plays important role in treating patients with PTSD

Posttraumatic stress disorder (PTSD) threatens to overload healthcare and social support systems worldwide as the number of cases rises and existing treatments are not sufficiently effective.

12 Feb 2010

Neurologix hires MTS Health Partners, L.P. as strategic advisor to augment business development activities

Neurologix, Inc., a biotechnology company engaged in the development of innovative therapies for the brain and central nervous system, today announced that it has hired MTS Health Partners, L.P. as strategic advisor to complement and augment the company’s ongoing business development activities.

12 Feb 2010

ISMPP announces opening of registration for 6th annual meeting on medical publications

The International Society for Medical Publication Professionals (ISMPP) is pleased to announce the opening of registration for its 6th annual meeting, "Delivering Value and Driving Advocacy in Medical Publications." The meeting will run from April 19 to 21, 2010, in Arlington, VA, at the Crystal Gateway Marriott.

12 Feb 2010

World leaders need to alter their notions on sustainable agriculture to prevent starvation catastrophe

Yields from some of the most important crops begin to decline sharply when average temperatures exceed about 30 degrees Celsius, or 86 Fahrenheit. Projections are that by the end of this century much of the tropics and subtropics will regularly see growing season temperatures above that level, hotter than the hottest summers now on record.

12 Feb 2010

Better and standardized animal models needed for musculoskeletal regenerative medicine

Clinical testing and development of novel therapies based on advances in tissue engineering and regenerative medicine that will one day enable the repair and replacement of diseased or damaged human muscle, bone, tendons, and ligaments depends on the availability of good animal models.

12 Feb 2010

Biotechnology News and Research

Max Neeman International forms specialized surgical team for conducting minimally invasive surgery studies

Teva Pharmaceutical Industries announces fourth-quarter and full-year 2009 financial results

Over 96% of SIDS cases due to known risk factors

US Oncology honored as inaugural inductee to Texas Governor's Business Hall of Fame

Teva Pharmaceuticals USA settles famciclovir patent litigation with Novartis

U.S. Department of Labor awards $4.95M grant for BRIDGE biotechnology project

International discussion held to find solutions for agricultural challenges of all time

Research findings may open door to new therapeutic strategies for serious health problems

High-resolution still images alongside high-speed video footage for detailed scientific imaging

Isogenica enters into agreement with Dstl to develop antimicrobial peptide drugs

TAP to showcase ambr system at Cell Line Development and Engineering 2010

Genencor launches Accellerase DUET at the 15th Annual National Ethanol Conference in Orlando

Free educational webinar: Important aspects to be aware of when selecting EHR system

Hypnosis has potential therapeutic value in children with respiratory disorders

GM crops can help bolster global food security, scientists say in special journal issue

VR technology plays important role in treating patients with PTSD

Neurologix hires MTS Health Partners, L.P. as strategic advisor to augment business development activities

ISMPP announces opening of registration for 6th annual meeting on medical publications

World leaders need to alter their notions on sustainable agriculture to prevent starvation catastrophe

Better and standardized animal models needed for musculoskeletal regenerative medicine

Event guide: 3rd IMPACCT Real World Evidence Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News